blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1032399

EP1032399 - PROGESTIN THERAPY WITH CONTROLLED BLEEDING [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  28.08.2009
Database last updated on 03.09.2024
Most recent event   Tooltip28.08.2009Application deemed to be withdrawnpublished on 30.09.2009  [2009/40]
Applicant(s)For all designated states
Columbia Laboratories (Bermuda) Limited
Rosebank Center, 14 Bermudiana Road
Pembroke HM08 / BM
[N/P]
Former [2000/36]For all designated states
Columbia Laboratories (Bermuda) Limited
Rosebank Center, 14 Bermudiana Road
Pembroke HM08 / BM
Inventor(s)01 / DE ZIEGLER, Dominique
6, rue de la Source
F-75016 Paris / FR
02 / BOLOGNA, William, J.
22, place de Général Catroux
F-75017 Paris / FR
03 / LEVINE, Howard, J.
107 Balsam Street
Oceanside, NY 11572 / US
[2000/36]
Representative(s)Keen, Celia Mary
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
[N/P]
Former [2000/36]Keen, Celia Mary
J.A. Kemp & Co. 14 South Square Gray's Inn
GB-London WC1R 5LX / GB
Application number, filing date98955011.621.10.1998
[2000/36]
WO1998US22169
Priority number, dateUS19970063485P21.10.1997         Original published format: US 63485 P
US1998017032613.10.1998         Original published format: US 170326
[2000/36]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9920282
Date:29.04.1999
Language:EN
[1999/17]
Type: A1 Application with search report 
No.:EP1032399
Date:06.09.2000
Language:EN
The application published by WIPO in one of the EPO official languages on 29.04.1999 takes the place of the publication of the European patent application.
[2000/36]
Search report(s)International search report - published on:EP29.04.1999
ClassificationIPC:A61K31/57
[2000/36]
CPC:
A61K31/57 (EP,KR,US); A61K9/0034 (EP,US); A61P15/00 (EP);
A61P15/12 (EP); A61P15/18 (EP); A61P5/00 (EP);
A61P5/24 (EP); A61P5/34 (EP); A61K47/32 (EP,US);
A61K9/7023 (EP,US) (-)
C-Set:
A61K31/57, A61K2300/00 (US,EP);
A61K31/57, A61K31/565 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2000/36]
Extension statesLT23.03.2000
LV23.03.2000
RO23.03.2000
TitleGerman:PROGESTINTHERAPIE MIT KONTROLLIERTER BLUTUNG[2000/36]
English:PROGESTIN THERAPY WITH CONTROLLED BLEEDING[2000/36]
French:TRAITEMENT A L'AIDE DE PROGESTINE PERMETTANT DE MAITRISER LES HEMORRAGIES[2000/36]
Entry into regional phase23.03.2000National basic fee paid 
23.03.2000Designation fee(s) paid 
23.03.2000Examination fee paid 
Examination procedure24.03.1999Request for preliminary examination filed
International Preliminary Examining Authority: EP
23.03.2000Examination requested  [2000/36]
14.10.2004Despatch of a communication from the examining division (Time limit: M04)
14.02.2005Reply to a communication from the examining division
04.10.2007Despatch of a communication from the examining division (Time limit: M04)
14.02.2008Reply to a communication from the examining division
05.11.2008Cancellation of oral proceeding that was planned for 27.11.2008
05.11.2008Minutes of oral proceedings despatched
27.11.2008Date of oral proceedings
27.11.2008Date of oral proceedings (cancelled)
28.11.2008Communication of intention to grant the patent
09.04.2009Application deemed to be withdrawn, date of legal effect  [2009/40]
13.05.2009Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2009/40]
Fees paidRenewal fee
09.10.2000Renewal fee patent year 03
11.10.2001Renewal fee patent year 04
15.10.2002Renewal fee patent year 05
14.10.2003Renewal fee patent year 06
14.10.2004Renewal fee patent year 07
12.10.2005Renewal fee patent year 08
12.10.2006Renewal fee patent year 09
12.10.2007Renewal fee patent year 10
31.10.2008Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DX]WO9507699  (COLUMBIA LAB INC [US]) [DX] 16-23 * claim - *;
 [X]  - WARREN M P ET AL, "Evaluation of Crinone, a Transvaginally Administered Progesterone Containing Bioadhesive Gel, in Women with Secondary Amenorrhea", MATURITAS, (1997), vol. 27, no. suppl.,F168, pages 95 - 96, XP002094217 [X] 1-23 * abstract *
 [X]  - WARDLE P ET AL, "Pilot Study of Continuous Combined Postmenopausal HRT Using Alternate Day or Twice Weekly Vaginal Progesterone", MATURITAS, (1997), vol. 27, no. suppl., F015, page 47, XP002094218 [X] 1-23 * abstract *
 [DX]  - FANCHIN R ET AL, "Transvaginal Administration of Progesterone", OBSTETRICS & GYNECOLOGY, (199709), vol. 90, no. 3, pages 396 - 401, XP002094219 [DX] 16-23 * abstract *

DOI:   http://dx.doi.org/10.1016/S0029-7844(97)00270-6
 [X]  - CASANAS-ROUX F ET AL, "Morphometric, Immunohistological and Three-Dimensional Evaluation of the Endometrium of Menopausal Women Treated by Oestrogen and Crinone, a New Slow-Release Vaginal Progesterone", HUMAN REPRODUCTION, (1996), vol. 11, no. 2, pages 357 - 363, XP002094220 [X] 16-23 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.